Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Angiotensin Receptor Antagonists"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 821
Tytuł:
Predicting Response to Immunotargeted Therapy in Endometrial Cancer via Tumor Immune Microenvironment: A Multicenter, Observational Study.
Autorzy:
Maltseva A; Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk 634050, Russia.
Kalinchuk A; Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk 634050, Russia.
Chernorubashkina N; Irkutsk Regional Oncology Center, 32 Frunze St., Irkutsk 664035, Russia.
Sisakyan V; Novosibirsk Regional Clinical Oncology Center, 2 Plakhotnogo St., Novosibirsk 630108, Russia.
Lots I; Novosibirsk Regional Clinical Oncology Center, 2 Plakhotnogo St., Novosibirsk 630108, Russia.
Gofman A; Altai Regional Oncological Dispensary, 110 Zmeinogorsky tr., Barnaul 656000, Russia.
Anzhiganova Y; Krasnoyarsk Regional Clinical Oncological Dispensary Named after A. I. Kryzhanovsky, 16 1-ya Smolenskaya St., Krasnoyarsk 660133, Russia.
Martynova E; Krasnoyarsk Regional Clinical Oncological Dispensary Named after A. I. Kryzhanovsky, 16 1-ya Smolenskaya St., Krasnoyarsk 660133, Russia.
Zukov R; Krasnoyarsk Regional Clinical Oncological Dispensary Named after A. I. Kryzhanovsky, 16 1-ya Smolenskaya St., Krasnoyarsk 660133, Russia.
Aleksandrova E; Yakut Republican Oncology Center, Build. 1, 81 Stadukhina St., Yakutsk 677005, Russia.
Kolomiets L; Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk 634050, Russia.
Tashireva L; Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk 634050, Russia.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Apr 01; Vol. 25 (7). Date of Electronic Publication: 2024 Apr 01.
Typ publikacji:
Journal Article; Multicenter Study; Observational Study
MeSH Terms:
Angiotensin Receptor Antagonists*
Endometrial Neoplasms*/drug therapy
Quinolines*
Female ; Humans ; Angiotensin-Converting Enzyme Inhibitors ; Phenylurea Compounds ; Tumor Microenvironment
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A Case of Trauma-Related Angioedema of the Airway in a Patient on an Angiotensin Receptor Blocker.
Autorzy:
Allihien SM; Department of Internal Medicine, Piedmont Athens Regional Medical Center, Athens, GA, USA.
Ibrahim S; Department of Internal Medicine, Piedmont Athens Regional Medical Center, Athens, GA, USA.
Chaparala S; Department of Internal Medicine, Piedmont Athens Regional Medical Center, Athens, GA, USA.
Singireddy S; Department of Internal Medicine, Piedmont Athens Regional Medical Center, Athens, GA, USA.
Kesiena O; Department of Internal Medicine, Piedmont Athens Regional Medical Center, Athens, GA, USA.
Pokaż więcej
Źródło:
The American journal of case reports [Am J Case Rep] 2024 Feb 28; Vol. 25, pp. e943407. Date of Electronic Publication: 2024 Feb 28.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Angiotensin Receptor Antagonists*/adverse effects
Angioedema*/chemically induced
Female ; Humans ; Aged, 80 and over ; Telmisartan/adverse effects ; Bradykinin ; Intubation ; Edema
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Knowledge, attitudes, and practices regarding antibiotic use and resistance among health science and non-health science university students in Thailand.
Autorzy:
Precha N; Department of Environmental Health and Technology, School of Public Health, Walailak University, Nakhon Si Thammarat, Thailand.; Excellent Center for Dengue and Community Public Health, Walailak University, Nakhon Si Thammarat, Thailand.
Sukmai S; Department of Environmental Health and Technology, School of Public Health, Walailak University, Nakhon Si Thammarat, Thailand.
Hengbaru M; Department of Environmental Health and Technology, School of Public Health, Walailak University, Nakhon Si Thammarat, Thailand.
Chekoh M; Department of Environmental Health and Technology, School of Public Health, Walailak University, Nakhon Si Thammarat, Thailand.
Laohaprapanon S; Department of Environmental Health and Technology, School of Public Health, Walailak University, Nakhon Si Thammarat, Thailand.
Makkaew P; Department of Environmental Health and Technology, School of Public Health, Walailak University, Nakhon Si Thammarat, Thailand.; Excellent Center for Dengue and Community Public Health, Walailak University, Nakhon Si Thammarat, Thailand.
Dom NC; Centre of Environmental Health and Safety Studies, Facultyof Health Sciences, Universiti Teknologi MARA (UiTM), Selangor, Malaysia.; Integrated Mosquito Research Group (I-MeRGe), Universiti Teknologi MARA (UiTM), Selangor, Malaysia.; Institute for Biodiversity and Sustainable Development (IBSD), Universiti Teknologi MARA (UiTM), Selangor, Malaysia.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Jan 05; Vol. 19 (1), pp. e0296822. Date of Electronic Publication: 2024 Jan 05 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Angiotensin Receptor Antagonists*
Health Knowledge, Attitudes, Practice*
Animals ; Humans ; Cross-Sectional Studies ; Thailand ; Universities ; Angiotensin-Converting Enzyme Inhibitors ; Students ; Anti-Bacterial Agents/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Medication profiling in women with type 1 diabetes highlights the importance of adequate, guideline-based treatment in low-risk groups.
Autorzy:
Lithovius R; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.; Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Mutter S; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.; Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Parente EB; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.; Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Mäkinen VP; Systems Epidemiology, Faculty of Medicine, University of Oulu, Oulu, Finland.; Research Unit of Population Health, Faculty of Medicine, University of Oulu, Oulu, Finland.
Valo E; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.; Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Harjutsalo V; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.; Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Chronic Disease Prevention Unit, National Institute for Health and Welfare, Helsinki, Finland.
Groop PH; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland. .; Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. .; Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland. .; Department of Diabetes, Central Clinical School, Monash University, Melbourne, VIC, Australia. .; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Biomedicum Helsinki, Helsinki University, Haartmaninkatu 8 [C318b], PO Box 63, 00014, Helsinki, Finland. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Oct 19; Vol. 13 (1), pp. 17893. Date of Electronic Publication: 2023 Oct 19.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Angiotensin Receptor Antagonists*/therapeutic use
Angiotensin Receptor Antagonists*/pharmacology
Diabetes Mellitus, Type 1*/drug therapy
Humans ; Female ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Angiotensin-Converting Enzyme Inhibitors/pharmacology ; Kidney ; Glomerular Filtration Rate
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Efficacy and Safety of Angiotensin Receptor Blockers in Pediatric Patients (Aged 6 to 18) with Hypertension: A Systematic Review.
Autorzy:
Bassiri S
Bakhtiari E
Ghaffarian N
Moazzen N
Ravanshad Y
Azarfar A; Kidney Transplantation Complications Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. .
Pokaż więcej
Źródło:
Iranian journal of kidney diseases [Iran J Kidney Dis] 2023 May; Vol. 17 (3), pp. 117-125.
Typ publikacji:
Systematic Review; Journal Article
MeSH Terms:
Angiotensin Receptor Antagonists*/adverse effects
Hypertension*/drug therapy
Child ; Humans ; Angiotensin-Converting Enzyme Inhibitors/pharmacology ; Antihypertensive Agents/adverse effects ; Losartan/adverse effects ; Tetrazoles/adverse effects ; Blood Pressure ; Receptors, Angiotensin/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
The impact of peroxisome proliferator-activated receptor-γ activating angiotensin receptor blocker on outcomes of patients receiving immunotherapy.
Autorzy:
Chiang CH; Department of Medicine, Mount Auburn Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Chang YC; Da Vinci Minimally Invasive Surgery Center, Chung Shan Medical University Hospital, Taichung, Taiwan.
Wang SS; Da Vinci Minimally Invasive Surgery Center, Chung Shan Medical University Hospital, Taichung, Taiwan.
Chen YJ; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
See XY; Department of Medicine, Unity Hospital, Rochester Regional Health, Rochester, New York, USA.
Peng CY; Department of Medicine, Danbury Hospital, Danbury, Connecticut, USA.
Hsia YP; Department of Family Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.
Chiang CH; Department of Medical Education, Kuang Tien General Hospital, Taichung, Taiwan.; London School of Hygiene & Tropical Medicine, London, UK.
Chiang CH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Department of General Division, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.
Peng CM; Da Vinci Minimally Invasive Surgery Center, Chung Shan Medical University Hospital, Taichung, Taiwan.; School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Apr; Vol. 12 (8), pp. 9583-9588. Date of Electronic Publication: 2023 Feb 24.
Typ publikacji:
Journal Article
MeSH Terms:
Angiotensin II Type 1 Receptor Blockers*/pharmacology
Angiotensin II Type 1 Receptor Blockers*/therapeutic use
Angiotensin Receptor Antagonists*/therapeutic use
Humans ; PPAR gamma/metabolism ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Immune Checkpoint Inhibitors/pharmacology ; Immune Checkpoint Inhibitors/therapeutic use ; Retrospective Studies ; Immunotherapy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Adaptation and initial validation of the Arabic version of the Word Memory Test (WMT ARB ).
Autorzy:
Bajjaleh C; Department of Psychology, the Academic College of Tel Aviv-Yaffo, Tel Aviv-Yaffo, Israel.
Braw YC; Department of Psychology, Ariel University, Ariel, Israel.
Elkana O; Department of Psychology, the Academic College of Tel Aviv-Yaffo, Tel Aviv-Yaffo, Israel.
Pokaż więcej
Źródło:
Applied neuropsychology. Adult [Appl Neuropsychol Adult] 2023 Mar-Apr; Vol. 30 (2), pp. 204-213. Date of Electronic Publication: 2021 May 27.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Angiotensin Receptor Antagonists*
Memory Disorders*/diagnosis
Adult ; Humans ; Angiotensin-Converting Enzyme Inhibitors ; Malingering/diagnosis ; Neuropsychological Tests ; Reproducibility of Results
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Angiotensin receptor-neprilysin inhibitor delays progression from paroxysmal to persistent atrial fibrillation.
Autorzy:
Dong Y; Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, No.1 of Minde Road, Nanchang, 330006, China.
Zhai Z; Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, No.1 of Minde Road, Nanchang, 330006, China.
Wang J; Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, No.1 of Minde Road, Nanchang, 330006, China.
Xia Z; Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, No.1 of Minde Road, Nanchang, 330006, China.
Xia Z; Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, No.1 of Minde Road, Nanchang, 330006, China.
Zhu B; Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, No.1 of Minde Road, Nanchang, 330006, China.
Dong Q; Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, No.1 of Minde Road, Nanchang, 330006, China.
Li Q; Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, No.1 of Minde Road, Nanchang, 330006, China.
Li J; Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, No.1 of Minde Road, Nanchang, 330006, China. juxiang__.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Feb 23; Vol. 13 (1), pp. 3140. Date of Electronic Publication: 2023 Feb 23.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Angiotensin Receptor Antagonists*/therapeutic use
Atrial Fibrillation*/drug therapy
Atrial Fibrillation*/prevention & control
Neprilysin*/antagonists & inhibitors
Humans ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Antihypertensive Agents/therapeutic use ; Receptors, Angiotensin ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Renin-Angiotensin-Aldosterone System Inhibitors and Development of Gynecologic Cancers: A 23 Million Individual Population-Based Study.
Autorzy:
Nguyen NTH; School of Health Care Administration, College of Management, Taipei Medical University, Taipei 11031, Taiwan.; Health Personnel Training Institute, University of Medicine and Pharmacy, Hue University, Hue 491-20, Vietnam.
Nguyen PA; Clinical Data Center, Office of Data Science, Taipei Medical University, Taipei 106339, Taiwan.; Clinical Big Data Research Center, Taipei Medical University Hospital, Taipei 11031, Taiwan.
Huang CW; International Center for Health Information Technology (ICHIT), College of Medical Science and Technology, Taipei Medical University, Taipei 106339, Taiwan.
Wang CH; Graduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, Taipei 106339, Taiwan.; Biomedical Informatics & Data Science (BIDS) Section, School of Medicine, Johns Hopkins University, 2024 E Monument St, Suite 1-200, Baltimore, MD 21205, USA.
Lin MC; Graduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, Taipei 106339, Taiwan.; Department of Neurosurgery, Shuang Ho Hospital, Taipei Medical University, New Taipei City 235041, Taiwan.; Taipei Neuroscience Institute, Taipei Medical University, Taipei 11031, Taiwan.
Hsu MH; Clinical Data Center, Office of Data Science, Taipei Medical University, Taipei 106339, Taiwan.; Graduate Institute of Data Science, College of Management, Taipei Medical University, Taipei 11031, Taiwan.
Bao HB; Health Personnel Training Institute, University of Medicine and Pharmacy, Hue University, Hue 491-20, Vietnam.; Internal Medicine Department, University of Medicine and Pharmacy, Hue University, Hue 491-20, Vietnam.
Chien SC; International Center for Health Information Technology (ICHIT), College of Medical Science and Technology, Taipei Medical University, Taipei 106339, Taiwan.; Graduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, Taipei 106339, Taiwan.
Yang HC; Clinical Big Data Research Center, Taipei Medical University Hospital, Taipei 11031, Taiwan.; International Center for Health Information Technology (ICHIT), College of Medical Science and Technology, Taipei Medical University, Taipei 106339, Taiwan.; Graduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, Taipei 106339, Taiwan.; Research Center of Big Data and Meta-Analysis, Wan Fang Hospital, Taipei Medical University, Taipei 116079, Taiwan.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Feb 14; Vol. 24 (4). Date of Electronic Publication: 2023 Feb 14.
Typ publikacji:
Journal Article
MeSH Terms:
Angiotensin Receptor Antagonists*/therapeutic use
Angiotensin-Converting Enzyme Inhibitors*/therapeutic use
Endometrial Neoplasms*/epidemiology
Hypertension*/drug therapy
Ovarian Neoplasms*/epidemiology
Renin-Angiotensin System*/drug effects
Female ; Humans ; Case-Control Studies ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effect of Bendopnea on Achievement Medical Treatment Target Doses in Heart Failure.
Autorzy:
Yılmaz Öztekin GM; Department of Cardiology, Antalya Training and Research Hospital, University of Health Sciences, Antalya, Turkey.
Genç A; Department of Cardiology, Antalya Training and Research Hospital, University of Health Sciences, Antalya, Turkey.
Şahin A; Department of Cardiology, Sivas Cumhuriyet University, Sivas, Turkey.
Çağırcı G; Department of Cardiology, Antalya Training and Research Hospital, University of Health Sciences, Antalya, Turkey.
Arslan Ş; Department of Cardiology, Antalya Training and Research Hospital, University of Health Sciences, Antalya, Turkey.
Pokaż więcej
Źródło:
Archives of Iranian medicine [Arch Iran Med] 2023 Jan 01; Vol. 26 (1), pp. 36-42. Date of Electronic Publication: 2023 Jan 01.
Typ publikacji:
Journal Article
MeSH Terms:
Angiotensin Receptor Antagonists*/therapeutic use
Heart Failure*/drug therapy
Heart Failure*/complications
Humans ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Dyspnea ; Adrenergic beta-Antagonists/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Angiotensin-receptor blocker losartan alleviates atrial fibrillation in rats by downregulating frizzled 8 and inhibiting the activation of WNT-5A pathway.
Autorzy:
Feng R; Department of Cardiovascular Medicine, The Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang City, Jiangxi Province, China.
Wan J; Department of Neurosurgery, The First Affiliated Hospital of Nanchang University, Nanchang City, Jiangxi Province, China.
He Y; Department of Neurosurgery, The First Affiliated Hospital of Nanchang University, Nanchang City, Jiangxi Province, China.
Gong H; Department of Cardiovascular Medicine, The Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang City, Jiangxi Province, China.
Xu Z; Department of Cardiovascular Medicine, The Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang City, Jiangxi Province, China.
Feng J; Department of Postgraduate, Medical College of Nanchang University, Nanchang City, Jiangxi Province, China.
Pokaż więcej
Źródło:
Clinical and experimental pharmacology & physiology [Clin Exp Pharmacol Physiol] 2023 Jan; Vol. 50 (1), pp. 19-27. Date of Electronic Publication: 2022 Oct 07.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Angiotensin Receptor Antagonists*/pharmacology
Atrial Fibrillation*/drug therapy
Losartan*/pharmacology
Animals ; Rats ; Angiotensin-Converting Enzyme Inhibitors ; Angiotensins ; Collagen ; Fibrosis ; Interleukin-6 ; Transforming Growth Factor beta1 ; Wnt Signaling Pathway
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Sacubitril/valsartan use patterns among older adults with heart failure in clinical practice: a population-based cohort study of >25 000 Medicare beneficiaries.
Autorzy:
Bhatt AS; Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Vaduganathan M; Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Solomon SD; Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Schneeweiss S; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Lauffenburger JC; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Desai RJ; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2022 Sep; Vol. 24 (9), pp. 1506-1515. Date of Electronic Publication: 2022 Jun 22.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Angiotensin Receptor Antagonists*/therapeutic use
Heart Failure*/chemically induced
Heart Failure*/drug therapy
Heart Failure*/epidemiology
Aged ; Aminobutyrates/therapeutic use ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Biphenyl Compounds/therapeutic use ; Cohort Studies ; Drug Combinations ; Humans ; Medicare ; Stroke Volume ; Tetrazoles/therapeutic use ; Treatment Outcome ; United States/epidemiology ; Valsartan/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Angiotensin receptor-neprilysin inhibitor attenuates cardiac hypertrophy and improves diastolic dysfunction in a mouse model of heart failure with preserved ejection fraction.
Autorzy:
Zhang Y; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, the Second Hospital of Tianjin Medical University, Tianjin, China.
Yuan M; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, the Second Hospital of Tianjin Medical University, Tianjin, China.
Suo Y; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, the Second Hospital of Tianjin Medical University, Tianjin, China.
Yang Q; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, the Second Hospital of Tianjin Medical University, Tianjin, China.
Shao S; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, the Second Hospital of Tianjin Medical University, Tianjin, China.
Li Y; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, the Second Hospital of Tianjin Medical University, Tianjin, China.
Wang Y; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, the Second Hospital of Tianjin Medical University, Tianjin, China.
Bao Q; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, the Second Hospital of Tianjin Medical University, Tianjin, China.
Liu T; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, the Second Hospital of Tianjin Medical University, Tianjin, China.
Li G; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, the Second Hospital of Tianjin Medical University, Tianjin, China.
Pokaż więcej
Źródło:
Clinical and experimental pharmacology & physiology [Clin Exp Pharmacol Physiol] 2022 Aug; Vol. 49 (8), pp. 848-857. Date of Electronic Publication: 2022 Jun 14.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Aminobutyrates*/pharmacology
Aminobutyrates*/therapeutic use
Angiotensin Receptor Antagonists*/pharmacology
Biphenyl Compounds*/pharmacology
Biphenyl Compounds*/therapeutic use
Cardiomegaly*/drug therapy
Heart Failure*/drug therapy
Heart Failure*/physiopathology
Neprilysin*/antagonists & inhibitors
Stroke Volume*/drug effects
Stroke Volume*/physiology
Valsartan*/pharmacology
Valsartan*/therapeutic use
Animals ; Diastole/drug effects ; Disease Models, Animal ; Drug Combinations ; Mice ; Receptors, Angiotensin/therapeutic use ; Tetrazoles/pharmacology ; Tetrazoles/therapeutic use ; Ventricular Dysfunction/drug therapy ; Ventricular Dysfunction/physiopathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Different cardiovascular responses to exercise training in hypertensive women receiving β-blockers or angiotensin receptor blockers: A pilot study.
Autorzy:
Mariano IM; Physical Education Department, Federal University of Uberlândia, Uberlândia, Brazil.
Amaral AL; Physical Education Department, Federal University of Uberlândia, Uberlândia, Brazil.
V Carrijo VH; Physical Education Department, Federal University of Uberlândia, Uberlândia, Brazil.
Costa JG; Physical Education Department, Federal University of Uberlândia, Uberlândia, Brazil.
Rodrigues ML; Physical Education Department, Federal University of Uberlândia, Uberlândia, Brazil.
Cunha TM; Medicine Department, Federal University of Uberlândia, Uberlândia, Brazil.
Puga GM; Physical Education Department, Federal University of Uberlândia, Uberlândia, Brazil.
Pokaż więcej
Źródło:
Clinical and experimental hypertension (New York, N.Y. : 1993) [Clin Exp Hypertens] 2022 Jul 04; Vol. 44 (5), pp. 442-450. Date of Electronic Publication: 2022 Apr 23.
Typ publikacji:
Clinical Study; Journal Article
MeSH Terms:
Adrenergic beta-Antagonists*/therapeutic use
Angiotensin Receptor Antagonists*/therapeutic use
Hypertension*/drug therapy
Hypertension*/physiopathology
Hypertension*/therapy
Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Blood Pressure/physiology ; Exercise/physiology ; Exercise Therapy ; Female ; Heart Rate/physiology ; Humans ; Pilot Projects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Pleiotropic activation of endothelial function by angiotensin II receptor blockers is crucial to their protective anti-vascular remodeling effects.
Autorzy:
Tehrani AY; Centre for Heart Lung Innovation, University of British Columbia, Vancouver, BC, Canada.; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, 2176 Health Sciences Mall, Room 217, Vancouver, BC, V6T 1Z3, Canada.
White Z; Centre for Heart Lung Innovation, University of British Columbia, Vancouver, BC, Canada.; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, 2176 Health Sciences Mall, Room 217, Vancouver, BC, V6T 1Z3, Canada.
Tung LW; School of Biomedical Engineering and Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.
Zhao RRY; Centre for Heart Lung Innovation, University of British Columbia, Vancouver, BC, Canada.; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, 2176 Health Sciences Mall, Room 217, Vancouver, BC, V6T 1Z3, Canada.
Milad N; Centre for Heart Lung Innovation, University of British Columbia, Vancouver, BC, Canada.; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, 2176 Health Sciences Mall, Room 217, Vancouver, BC, V6T 1Z3, Canada.
Seidman MA; Centre for Heart Lung Innovation, University of British Columbia, Vancouver, BC, Canada.; Laboratory Medicine Program, University Health Network, Toronto, ON, Canada.
Sauge E; Centre for Heart Lung Innovation, University of British Columbia, Vancouver, BC, Canada.; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, 2176 Health Sciences Mall, Room 217, Vancouver, BC, V6T 1Z3, Canada.
Theret M; School of Biomedical Engineering and Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.
Rossi FMV; School of Biomedical Engineering and Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.
Esfandiarei M; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, 2176 Health Sciences Mall, Room 217, Vancouver, BC, V6T 1Z3, Canada.; Department of Biomedical Sciences, College of Graduate Studies, Midwestern University, Glendale, AZ, USA.
van Breemen C; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, 2176 Health Sciences Mall, Room 217, Vancouver, BC, V6T 1Z3, Canada.
Bernatchez P; Centre for Heart Lung Innovation, University of British Columbia, Vancouver, BC, Canada. .; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, 2176 Health Sciences Mall, Room 217, Vancouver, BC, V6T 1Z3, Canada. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Jun 13; Vol. 12 (1), pp. 9771. Date of Electronic Publication: 2022 Jun 13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:
Angiotensin II Type 1 Receptor Blockers*/pharmacology
Angiotensin Receptor Antagonists*
Angiotensin II/metabolism ; Angiotensin-Converting Enzyme Inhibitors/pharmacology ; Animals ; Mice ; Nitric Oxide/metabolism ; Receptor, Angiotensin, Type 1/genetics ; Receptor, Angiotensin, Type 1/metabolism ; Telmisartan/pharmacology ; Vascular Remodeling
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The effects of antibiotic cycling and mixing on acquisition of antibiotic resistant bacteria in the ICU: A post-hoc individual patient analysis of a prospective cluster-randomized crossover study.
Autorzy:
van Duijn PJ; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, Utrecht, Netherlands.
Verbrugghe W; Department of Critical Care Medicine, Antwerp University Hospital, University of Antwerp, Edegem, Belgium.
Jorens PG; Department of Critical Care Medicine, Antwerp University Hospital, University of Antwerp, Edegem, Belgium.
Spöhr F; Department of Anaesthesiology and Intensive Care, Sana Kliniken Stuttgart, Stuttgart, Germany.
Schedler D; Department of Anaesthesiology and Intensive Care, Sana Kliniken Stuttgart, Stuttgart, Germany.
Deja M; Klinik für Anästhesiologie und Intensivmedizin, Universitätsklinikum Schleswig-Holstein, Lübeck, Germany.
Rothbart A; Department of Anesthesiology and Operative Intensive Care Medicine, Charité Universitätsmedizin, Berlin, Germany.
Annane D; Department of Intensive Care, Hôpital Raymond Poincaré (APHP), Garches, France.; Laboratory of Infection & Inflammation, School of Medicine Simone Veil, University Versailles Saint Quentin & University Paris Saclay, INSERM, Montigny le Bretonneux, France.; FHU SEPSIS (Saclay and Paris Seine Nord Endeavour to PerSonalize Interventions for Sepsis) and RHU RECORDS (Rapid rEcognition of CORticosteroiD resistant or sensitive Sepsis), Garches, France.
Lawrence C; Microbiology Unit, Raymond-Poincaré Hospital, Garches, France.
Jereb M; Department of Infectious Diseases, University Medical Centre, Ljubljana, Slovenia.; Medical Faculty, University of Ljubljana, Ljubljana, Slovenia.
Seme K; Faculty of Medicine, Institute of Microbiology and Immunology, University of Ljubljana, Ljubljana, Slovenia.
Šifrer F; Department of Intensive Care Medicine, University Hospital Golnik, Golnik, Slovenia.
Tomič V; Department of Medical Microbiology, University Hospital Golnik, Golnik, Slovenia.
Estevez F; Intensive Care Unit and Emergency Department, Centro Hospitalar Trás-os-Montes e Alto Douro, Vila Real, Portugal.
Carneiro J; Intensive Care Unit and Emergency Department, Centro Hospitalar Trás-os-Montes e Alto Douro, Vila Real, Portugal.
Harbarth S; Infection Control Program, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
Bonten MJM; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, Utrecht, Netherlands.; Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, Netherlands.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 May 03; Vol. 17 (5), pp. e0265720. Date of Electronic Publication: 2022 May 03 (Print Publication: 2022).
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Angiotensin Receptor Antagonists*/pharmacology
Angiotensin-Converting Enzyme Inhibitors*/pharmacology
Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Carbapenems/pharmacology ; Cephalosporins/pharmacology ; Cross-Over Studies ; Gram-Negative Bacteria ; Humans ; Intensive Care Units ; Piperacillin/pharmacology ; Prospective Studies ; Pseudomonas aeruginosa ; Tazobactam/pharmacology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Diarrhea and angiotensin II receptor blockers: Is there any difference between the different drugs?
Autorzy:
Guion-Firmin J; Service de Pharmacologie Médicale et Clinique, Centre de Pharmacovigilance, de Pharmacoépidemiologie et d'Informations sur le Médicament, CIC INSERM 1436, Centre Hospitalier Universitaire-Faculté de Médecine, Toulouse, France.
Tessier S; Service de Pharmacologie Médicale et Clinique, Centre de Pharmacovigilance, de Pharmacoépidemiologie et d'Informations sur le Médicament, CIC INSERM 1436, Centre Hospitalier Universitaire-Faculté de Médecine, Toulouse, France.
Montastruc JL; Service de Pharmacologie Médicale et Clinique, Centre de Pharmacovigilance, de Pharmacoépidemiologie et d'Informations sur le Médicament, CIC INSERM 1436, Centre Hospitalier Universitaire-Faculté de Médecine, Toulouse, France.
Pokaż więcej
Źródło:
Fundamental & clinical pharmacology [Fundam Clin Pharmacol] 2022 Apr; Vol. 36 (2), pp. 443-447. Date of Electronic Publication: 2021 Dec 02.
Typ publikacji:
Journal Article
MeSH Terms:
Angiotensin Receptor Antagonists*/adverse effects
Diarrhea*/chemically induced
Hypertension*/drug therapy
Aged ; Angiotensin-Converting Enzyme Inhibitors/adverse effects ; Antihypertensive Agents/adverse effects ; Female ; Humans ; Telmisartan/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Sacubitril/valsartan, sodium-glucose cotransporter 2 inhibitors and vericiguat for congestive heart failure therapy.
Autorzy:
Norre T; Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Grimm D; Department of Biomedicine, Aarhus University, Aarhus, Denmark.; Department of Microgravity and Translational Regenerative Medicine, Clinic for Plastic, Aesthetic and Hand Surgery, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.
Simonsen U; Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Pokaż więcej
Źródło:
Basic & clinical pharmacology & toxicology [Basic Clin Pharmacol Toxicol] 2022 Apr; Vol. 130 (4), pp. 425-438. Date of Electronic Publication: 2022 Feb 17.
Typ publikacji:
Journal Article; Review; Systematic Review
MeSH Terms:
Angiotensin Receptor Antagonists*/therapeutic use
Heart Failure*/drug therapy
Aminobutyrates/adverse effects ; Biphenyl Compounds ; Drug Combinations ; Glucose/therapeutic use ; Heterocyclic Compounds, 2-Ring ; Humans ; Pyrimidines ; Sodium ; Tetrazoles/adverse effects ; Treatment Outcome ; Valsartan/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Diarrhoea with the angiotensin receptor neprilysin inhibitor sacubitril + valsartan: A pharmacovigilance study.
Autorzy:
Guion-Firmin J; Service de Pharmacologie Médicale et Clinique, Centre de Pharmacovigilance de Pharmacoépidemiologie et d'Informations sur le Médicament, CIC INSERM 1436, Centre Hospitalier Universitaire-Faculté de Médecine, Toulouse, France.
Tessier S; Service de Pharmacologie Médicale et Clinique, Centre de Pharmacovigilance de Pharmacoépidemiologie et d'Informations sur le Médicament, CIC INSERM 1436, Centre Hospitalier Universitaire-Faculté de Médecine, Toulouse, France.
Lepelley M; Centre de Pharmacovigilance, Centre Hospitalier Universitaire, Université de Grenoble, Grenoble, France.
Faillie JL; Centre de Pharmacovigilance, Centre Hospitalier Universitaire, Université de Montpellier, Montpellier, France.
Montastruc JL; Service de Pharmacologie Médicale et Clinique, Centre de Pharmacovigilance de Pharmacoépidemiologie et d'Informations sur le Médicament, CIC INSERM 1436, Centre Hospitalier Universitaire-Faculté de Médecine, Toulouse, France.
Pokaż więcej
Źródło:
Fundamental & clinical pharmacology [Fundam Clin Pharmacol] 2022 Apr; Vol. 36 (2), pp. 378-389. Date of Electronic Publication: 2021 Jul 29.
Typ publikacji:
Journal Article
MeSH Terms:
Angiotensin Receptor Antagonists*
Diarrhea*/chemically induced
Diarrhea*/epidemiology
Neprilysin*/antagonists & inhibitors
Valsartan*/adverse effects
Aminobutyrates/adverse effects ; Biphenyl Compounds/adverse effects ; Drug Combinations ; Female ; Humans ; Male ; Pharmacovigilance ; Receptors, Angiotensin ; Tetrazoles/adverse effects ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Electromyographic Comparison of an Abdominal Rise on a Ball with a Traditional Crunch.
Autorzy:
Dolenec A; Faculty of Sport, University of Ljubljana, 1000 Ljubljana, Slovenia.
Svetina M; Faculty of Sport, University of Ljubljana, 1000 Ljubljana, Slovenia.
Strojnik V; Faculty of Sport, University of Ljubljana, 1000 Ljubljana, Slovenia.
Pokaż więcej
Źródło:
Sensors (Basel, Switzerland) [Sensors (Basel)] 2022 Mar 03; Vol. 22 (5). Date of Electronic Publication: 2022 Mar 03.
Typ publikacji:
Journal Article
MeSH Terms:
Angiotensin Receptor Antagonists*
Angiotensin-Converting Enzyme Inhibitors*
Abdominal Muscles/physiology ; Adult ; Electromyography ; Exercise/physiology ; Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 821

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies